Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | EVP, General Counsel | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 616,761 |
Ending reported balance
After 2026-03-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-02-27 · Tax withholding · Disposed 26,326 · Balance 782,932 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 2 · 2026-03-02 · Sale · Disposed 6,856 · Balance 776,076 F2: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. Row 3 · 2026-03-02 · Tax withholding · Disposed 16,973 · Balance 759,103 F3: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 4 · 2026-03-02 · Other · Disposed 137,922 · Balance 621,181 F4: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e). Row 5 · 2026-03-03 · Sale · Disposed 4,420 · Balance 616,761 F5: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.
F3: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F4: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e).
F5: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2026 Filed Mar 3, 2026 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 4,420 | $5.77 | $25,503.40 |
DisclosureSEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 5 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616,761 F5 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | OtherCommon Shares, No Par Value | 137,922 | $5.95 | $820,635.90 |
DisclosureSEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 4 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 621,181 F4 · shares: Reflects the disposition in cash as contemplated by paragraph 7(1)(b) of the Income Tax Act (Canada) of 137,922 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The disposition in cash is exempt under Rule 16b-3(e). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 16,973 | $5.95 | $100,989.35 |
DisclosureSEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 759,103 F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 6,856 | $5.78 | $39,627.68 |
DisclosureSEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 776,076 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. Read SEC document |
| February 27, 2026 Filed Feb 27, 2026 22:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 8,388 | $5.95 | $49,908.60 |
DisclosureSEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 809,258 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 7, 2025. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 22:43 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 26,326 | $5.93 | $156,113.18 |
DisclosureSEC source: 0000885590-26-000039 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 782,932 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 22:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 32,211 | $6.04 | $194,554.44 |
DisclosureSEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 817,646 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:19 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 212,350 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000031 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,857 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 23:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 137,922 | $0.00 | $0.00 |
DisclosureSEC source: 0000885590-26-000011 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 637,507 F1 · shares: Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter. Read SEC document |
| September 08, 2025 Filed Sep 8, 2025 20:37 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 13,370 | $7.31 | $97,734.70 |
DisclosureSEC source: 0001127602-25-021221 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 499,585 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 7, 2025. Read SEC document |
| September 05, 2025 Filed Sep 8, 2025 20:37 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 51,337 | $7.35 | $377,326.95 |
DisclosureSEC source: 0001127602-25-021221 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,955 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:05 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 26,325 | $7.44 | $195,858.00 |
DisclosureSEC source: 0001127602-25-007477 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 564,292 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:05 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 16,973 | $7.44 | $126,279.12 |
DisclosureSEC source: 0001127602-25-007477 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590,617 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:05 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,994 | $7.44 | $44,595.36 |
DisclosureSEC source: 0001127602-25-007477 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607,590 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:42 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 180,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007287 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,584 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 440 | $8.35 | $3,674.00 |
DisclosureSEC source: 0001127602-24-028415 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 433,066 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:07 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,692 | $8.37 | $14,162.04 |
DisclosureSEC source: 0001127602-24-028415 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 433,506 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 20:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 13,370 | $6.21 | $83,027.70 |
DisclosureSEC source: 0001127602-24-023693 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,198 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:54 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 51,337 | $6.19 | $317,776.03 |
DisclosureSEC source: 0001127602-24-023693 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 448,568 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 133 | $9.80 | $1,303.40 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 9 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 499,905 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 1,561 | $9.80 | $15,297.80 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 8 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500,038 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 199 | $9.80 | $1,950.20 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 7 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 501,599 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 4,420 | $9.80 | $43,316.00 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 6 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 501,798 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 511 | $9.89 | $5,053.79 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 5 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 506,218 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 16,973 | $9.89 | $167,862.97 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 4 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 506,729 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,994 | $9.89 | $59,280.66 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 523,702 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 765 | $9.89 | $7,565.85 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,696 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 147,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008121 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 530,461 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| December 05, 2023 Filed Dec 5, 2023 21:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 220 | $7.38 | $1,623.60 |
DisclosureSEC source: 0001127602-23-028885 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,925 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:35 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,691 | $7.36 | $12,445.76 |
DisclosureSEC source: 0001127602-23-028885 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 383,145 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| November 06, 2023 Filed Nov 6, 2023 22:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 43 | $7.61 | $327.23 |
DisclosureSEC source: 0001127602-23-026852 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,836 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 22:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 334 | $7.57 | $2,528.38 |
DisclosureSEC source: 0001127602-23-026852 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 384,879 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 20:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 6,685 | $8.28 | $55,351.80 |
DisclosureSEC source: 0001127602-23-023786 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,213 F2 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 51,337 | $8.35 | $428,663.95 |
DisclosureSEC source: 0001127602-23-023786 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 391,898 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 06, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 495 | $9.17 | $4,539.15 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 8 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,235 F4 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:50 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 495 | $9.17 | $4,539.15 |
DisclosureSEC source: 0001127602-23-009310 · form4a.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,235 F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. F2 · shares: This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S". Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 780 | $9.34 | $7,285.20 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 7 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,730 F4 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 887 | $9.16 | $8,124.92 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 6 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,510 F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,637 | $9.16 | $14,994.92 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 5 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,397 F3 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of performance-based Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 511 | $9.16 | $4,680.76 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 4 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,034 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 765 | $9.16 | $7,007.40 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,545 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:50 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 780 | $9.34 | $7,285.20 |
DisclosureSEC source: 0001127602-23-009310 · form4a.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,730 F1 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. F2 · shares: This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S". Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 82,117 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · derivative · entry 9 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,117 Underlying: Common Shares, No Par Value · 82,117 shares Expires 2033-03-02 F5 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 95,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,310 F2 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:52 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,994 | $9.25 | $55,444.50 |
DisclosureSEC source: 0001127602-23-009099 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,191 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 22:45 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | SaleCommon Shares, No Par Value | 292 | $9.32 | $2,721.44 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 3 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,185 F3 · shares: Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:45 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 768 | $9.57 | $7,349.76 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 2 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,477 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:45 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,474 | $9.57 | $14,106.18 |
DisclosureSEC source: 0001127602-23-007989 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,245 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 21:17 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,691 | $7.70 | $13,020.70 |
DisclosureSEC source: 0001127602-22-026766 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,719 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 20:06 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 334 | $6.45 | $2,154.30 |
DisclosureSEC source: 0001127602-22-024963 · form4.xml · nonDerivative · entry 1 Carson Seana · CIK 0001923756 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 363,410 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.